Clinical Impact and Cost Efficacy of Newborn Screening for Congenital Adrenal Hyperplasia

To evaluate the clinical impact of a congenital adrenal hyperplasia (CAH) newborn screening program and incremental costs relative to benefits in screened vs unscreened infants. We hypothesized that screening would lead to clinical benefits and would be cost effective.

Source: The Journal of Pediatrics - February 6, 2020 Category: Pediatrics Authors: Danya A. Fox, Rebecca Ronsley, Asif R. Khowaja, Alon Haim, Hilary Vallance, Graham Sinclair, Shazhan Amed Tags: Original Articles Source Type: research